Stocks · Health care · Pharmaceutical Preparations

PepGen Inc.

PEPG Clue Score35
United States Fiscal year ends December CIK 0001835597 Results filed 6 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Kasra Kasraian
21 May 2026
Chief Technical Officer
Sell
1,233
$1.41
$1.74K
James G McArthur
4 Mar 2026
President and CEO
Sell
131
$6.33
$828.58
James G McArthur
4 Mar 2026
President and CEO
Sell
5,144
$6.23
$32.05K
Noel Donnelly
4 Mar 2026
Chief Financial Officer
Sell
52
$6.33
$328.90
Noel Donnelly
4 Mar 2026
Chief Financial Officer
Sell
2,032
$6.23
$12.66K
Paul Streck
4 Mar 2026
EVP, Head of R&D
Sell
47
$6.29
$295.54
Paul Streck
4 Mar 2026
EVP, Head of R&D
Sell
1,832
$6.23
$11.41K
Noel Donnelly
26 Feb 2025
Chief Financial Officer
Sell
1,527
$1.68
$2.57K
Mary Beth DeLena
26 Feb 2025
General Counsel
Sell
1,432
$1.68
$2.41K
Niels Svenstrup
17 May 2024
SVP, Chem. Mfg & Controls
Sell
10,000
$13.41
$134.10K

What was left out

Form 4 filings counted 98
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 21
Sales at will 10
Transactions with no price 0
Shares from compensation/vesting 9,848,749
History held since 10 May 2022